ACTRN12613000315718已完成不适用
Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house dust mites: A Double-Blind-Placebo-Controlled Randomised Trial
Marmara University medical faculty0 个研究点目标入组 60 人开始时间: 2013年3月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 5 Years 至 10 Years(—)
- 性别
- All
入选标准
- •Children aged between 5-10 years of both genders with the history of persistent allergic rhinitis without asthmatic symptoms.
排除标准
- •Allergic asthma, previous allergen immunotherapy, chronic disease, malignancy.
研究者
相似试验
招募中
不适用
Efficacy of sublingual allergen immunotherapy in asthma with allergic rhinitisAsthma with allergic rhinitisJPRN-UMIN000022390Atami Hospital, International University of Health and Welfare100
进行中(未招募)
不适用
Study on the effectiveness of allergen immunotherapy in patients with house dust mite-induced allergic rhinitis and other associated allergic conditionsISRCTN32263767Hong Kong Sanatorium & Hospital120
进行中(未招募)
不适用
A study, which aims to evaluate the efficacy and safety of LAIS® Birch-Alder tablets in patients suffering from allergic inflammation of the conjunctiva and rhinitis caused by birch pollePatients suffering from allergic rhinoconjunctivitisMedDRA version: 17.1Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisSystem Organ Class: 100000004853EUCTR2013-002129-43-DEofarma S.p.A.
进行中(未招募)
1 期
Efficacy and Safety of sublingual immunotherapy with Allergoid LAIS Birch tablets for patients with tree pollen-induced allergic rhinoconjunctivitis with or without mild controlled asthmaEUCTR2018-002596-18-ITOFARMA S.P.A.110
进行中(未招募)
1 期
A study which aims at evaluating the efficacy and safety of LAIS® Grass tablets in patients suffering from g from allergic inflammation of the conjunctiva and rhinitis which are caused by grass pollePatients suffering from allergic rhinoconjunctivitisMedDRA version: 16.1Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisSystem Organ Class: 100000004853EUCTR2012-004916-79-DEofarma S.p.A.200
